| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6242003 | SANDOZ | Organic compounds |
Apr, 2020
(4 years ago) | |
|
US6242003 (Pediatric) | SANDOZ | Organic compounds |
Oct, 2020
(3 years ago) | |
Lescol Xl is owned by Sandoz.
Lescol Xl contains Fluvastatin Sodium.
Lescol Xl has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Lescol Xl are:
- US6242003
- US6242003*PED
Lescol Xl was authorised for market use on 06 October, 2000.
Lescol Xl is available in tablet, extended release;oral dosage forms.
The generics of Lescol Xl are possible to be released after 13 October, 2020.
Drugs and Companies using FLUVASTATIN SODIUM ingredient
Market Authorisation Date: 06 October, 2000
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of LESCOL XL before it's drug patent expiration?
More Information on Dosage
LESCOL XL family patents
